英诺特(688253) - 2024 Q4 - 年度业绩

Financial Performance - The company achieved total operating revenue of 621.34 million yuan, a year-on-year increase of 29.98%[2] - Net profit attributable to the parent company reached 245.69 million yuan, reflecting a year-on-year growth of 41.24%[5] - The net profit excluding non-recurring gains and losses grew by 47.52% year-on-year, reaching 216.93 million yuan[9] - Basic earnings per share increased by 41.41% to 1.81 yuan[2] - The increase in operating profit by 37.12% and total profit by 38.50% is attributed to favorable market conditions in the respiratory testing sector[9] Assets and Returns - The company's total assets at the end of the reporting period were 2.22 billion yuan, an increase of 7.33% from the beginning of the period[5] - The weighted average return on net assets rose to 12.67%, an increase of 2.8 percentage points compared to the previous year[2] Strategic Initiatives - The company plans to enhance its core competitive advantages by increasing investments in channel network construction and international market access[7] - The company is focusing on digital and intelligent upgrades to improve operational efficiency and risk control capabilities[7] Cautionary Note - The company warns that the financial data presented are preliminary and subject to final audit, urging investors to be cautious[10]